- Home
- ONDS vs XOMA Comparison
ONDS vs XOMA Comparison
Compare ONDS & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONDS
- XOMA
- Stock Information
- Founded
- ONDS 2014
- XOMA 1981
- Country
- ONDS United States
- XOMA United States
- Employees
- ONDS N/A
- XOMA N/A
- Industry
- ONDS Telecommunications Equipment
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- ONDS Telecommunications
- XOMA Health Care
- Exchange
- ONDS Nasdaq
- XOMA Nasdaq
- Market Cap
- ONDS 1.4B
- XOMA 330.2M
- IPO Year
- ONDS N/A
- XOMA N/A
- Fundamental
- Price
- ONDS $5.86
- XOMA $32.47
- Analyst Decision
- ONDS Strong Buy
- XOMA Strong Buy
- Analyst Count
- ONDS 3
- XOMA 2
- Target Price
- ONDS $4.67
- XOMA $69.50
- AVG Volume (30 Days)
- ONDS 49.3M
- XOMA 57.0K
- Earning Date
- ONDS 08-12-2025
- XOMA 08-13-2025
- Dividend Yield
- ONDS N/A
- XOMA N/A
- EPS Growth
- ONDS N/A
- XOMA N/A
- EPS
- ONDS N/A
- XOMA N/A
- Revenue
- ONDS $16,131,404.00
- XOMA $44,952,000.00
- Revenue This Year
- ONDS $246.94
- XOMA $82.30
- Revenue Next Year
- ONDS $161.09
- XOMA $12.59
- P/E Ratio
- ONDS N/A
- XOMA N/A
- Revenue Growth
- ONDS 75.16
- XOMA 194.98
- 52 Week Low
- ONDS $0.57
- XOMA $18.35
- 52 Week High
- ONDS $6.19
- XOMA $35.23
- Technical
- Relative Strength Index (RSI)
- ONDS 79.19
- XOMA 61.79
- Support Level
- ONDS $3.20
- XOMA $32.60
- Resistance Level
- ONDS $4.33
- XOMA $34.60
- Average True Range (ATR)
- ONDS 0.54
- XOMA 1.82
- MACD
- ONDS 0.17
- XOMA 0.09
- Stochastic Oscillator
- ONDS 89.02
- XOMA 66.75
About ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.